Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amgen Investing $550M in New Biomanufacturing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Amgen Investing $550M in New Biomanufacturing Facility

Will create 355 new jobs at Holly Springs, NC site.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amgen has unveiled plans to build a new $550 million biologics manufacturing facility in Holly Springs, NC, creating 355 jobs along the way. The new site in the Research Triangle area of North Carolina will bring a biologics drug substance manufacturing plant online to help the company continue to meet the production demands for its medicines.
 
“Amgen is investing in a technologically-advanced drug substance plant in North Carolina to support the expected increase in demand for our medicines,” Esteban Santos, executive vice president, Amgen. “Together with the previously announced advanced packaging plant in Ohio, we have committed to investing nearly $1 billion in new manufacturing capacity in the U.S.”
 
The Amgen facility in North Carolina will be built to exacting environmental standards, consistent with the company’s goal of achieving carbon neutrality, reduce water use by 40% and waste disposal by 75% by 2027. The facility also will support Amgen’s participation as a founding member of OneTen, a coalition of many of the world’s largest, best-known companies that aims collectively to hire one million Black Americans into well-paying jobs over the next ten years, with a specific focus on those without a four-year college degree.
 
“World-class companies like Amgen are very selective when they evaluate business locations and they only choose places that provide the best support for their operations,” said Governor Cooper. “Today’s decision proves once again that North Carolina remains a premier location for the most innovative biotech companies in the industry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics